CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570)
Athera Biotechnologies develops a biomarker and companion diagnostic VCDefine kit. The biomaker, anti-PC, is linked to increased risk for cardiovascular disease and could in the future be used for identification of patients that benefit from Athera's...Show all
Company (Alive / Active)
Phone: +46 76 1938 190
Sankt Eriksgatan 117
4th floor
Stockholm, SE-113 43
Sweden
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Antibodies against phosphorylcholine | Aug 08, 2012 | Oct 31, 2017 | Patent |
| Antibodies binding to phosphorylcholine (pc) and/or pc conjugates | Aug 08, 2012 | Oct 24, 2017 | Patent |
| Phosphorylcholine conjugates and corresponding antibodies | Apr 15, 2005 | Sep 06, 2011 | Patent |
| Method of diagnosing cardiovascular disease | Apr 01, 2004 | Feb 16, 2010 | Patent |
| Antibodies binding to phosphorylcholine (pc) and/or pc conjugates | Sep 28, 2017 | Application |
